Danaher

DHR · NYSE

$224.24−$0.19 (−0.08%)TodayMarket closed ·
Prev close $224.43

Latest news

  • NewsKaustubh Bagalkote

    Meta Platforms, Tesla Could Swing More Than $100 Billion After Earnings

  • NewsAvi Kapoor

    Danaher Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

  • NewsKaustubh Bagalkote

    Lam Research Could Swing $28.6 Billion After Earnings

  • NewsAkanksha Bakshi

    Danaher Brings NVIDIA AI Into Scientific Instruments in Push for Faster Discoveries

  • NewsNeeraj Jain

    What's Going On With NVIDIA Stock Wednesday?

  • Press releasePRNewswire

    Danaher Collaborates with NVIDIA to Advance Autonomous Science

  • Press releasePRNewswire

    Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors

  • Press releasePRNewswire

    Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab

  • Press releasePRNewswire

    Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer

  • Press releasePRNewswire

    Danaher Schedules Third Quarter 2026 Earnings Conference Call

  • Press releaseBusiness Wire

    Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to Development

  • Press releasePRNewswire

    Danaher Announces Quarterly Dividend

  • Press releasePRNewswire

    Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer

  • NewsLekha Gupta

    Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets

  • NewsMark Putrino

    Stock Of The Day: Is The Danaher Selloff Over?

  • NewsAvi Kapoor

    Crude Oil Surges 2%; 3M Shares Gain After Q2 Results

  • NewsPiero Cingari

    Micron Leads Memory-Stock Rally, Nasdaq 100 Tops 29,000: Stock Market Today

  • NewsVandana Singh

    Why Danaher Stock Just Tanked 14%

  • News

    Transcript: Danaher Q2 2026 Earnings Conference Call

  • Press releasePRNewswire

    Danaher Reports Second Quarter 2026 Results

  • NewsKaustubh Bagalkote

    Intel Could Swing $61.4 Billion in Value After Earnings This Week

  • Press releaseBusiness Wire

    Audax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica Biosystems

  • NewsVandana Singh

    Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover

  • News

    9 Health Care Stocks Whale Activity In Today’s Session

  • Press releasePRNewswire

    Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releasePRNewswire

    Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa

  • Press releasePRNewswire

    Danaher Schedules Second Quarter 2026 Earnings Conference Call

  • Press releaseBusiness Wire

    Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner

  • Press releasePRNewswire

    Danaher Completes Acquisition of Masimo Corporation

  • Press releasePRNewswire

    Sirius XM Holdings Set to Join S&P MidCap 400

  • Press releaseBusiness Wire

    SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools

  • Press releaseBusiness Wire

    SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations

  • Press releaseBusiness Wire

    Henry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the Board

  • NewsTanya Rawat

    Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'

  • Press releasePRNewswire

    Danaher Reports Fourth Quarter and Full Year 2025 Results

  • Press releasePRNewswire

    Danaher Reports Fourth Quarter and Full Year 2024 Results

  • Press releasePRNewswire

    Danaher Reports Third Quarter 2024 Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.